We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Domainex and Pharmidex Announce Drug Discovery Services Alliance
News

Domainex and Pharmidex Announce Drug Discovery Services Alliance

Domainex and Pharmidex Announce Drug Discovery Services Alliance
News

Domainex and Pharmidex Announce Drug Discovery Services Alliance

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Domainex and Pharmidex Announce Drug Discovery Services Alliance"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Domainex Ltd and Pharmidex announced the formation of a strategic alliance, combining their expertise and technologies to provide the market with an integrated, high-quality drug discovery services platform.

The joint service offering will amalgamate Domainex’s LeadBuilder technology for hit-finding, as well as its highly-experienced medicinal chemistry team, with Pharmidex’s renowned expertise and in vitro and in vivo capabilities in drug metabolism and pharmacokinetics (DMPK).

Concordant with the established track records of both partners, the alliance will have a particular emphasis on tackling the most challenging of scientific problems, including novel or “difficult” drug targets.
Advertisement